BioSpace News Archive

The global spinal muscular atrophy market witnesses substantial competition with the presence of a considerable number of market participants of varying sizes, says Transparency Market Research in a new market study.

A recent report on the global fragment based drug discovery market studied by Transparency Market Research elaborates the factors that indicates the growth of the market in coming years.

CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the wor

-- Once-weekly formulation of setmelanotide achieved weight loss efficacy comparable to daily-dosing formulation – -- Both weekly and daily formulations of setmelanotide were observed to be safe and well-tolerated – -- Pharmacokinetics analysis showed weekly formulation of setmelanotide trough drug concentration similar to daily formulation –

IBEX Technologies Inc. reported its financial results for the nine months ended April 30, 2020.

Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that it has joined the broad-market Russell 3000 Ò Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective Monday, June 29 th 2020 after the U.S. market opening. Annual Russell indexes reconstitution captures t

Cytovia Therapeutics, Inc (“Cytovia”), an emerging biopharmaceutical company developing Natural Killer (NK) immunotherapies for cancer, today announces the appointment of Dr. Leila Alland and Ms. Jane Wasman to its Board of Directors, effective immediately. Dr. Leila Alland brings extensive experience in oncology drug development to her role at Cytovia Therapeutics. Dr. Alland is currently Chief Medical Officer at PMV Pharma, a leader in the discov

Fewer Than One Percent of All Rated Organizations Have Received the Distinction With This Consistency

Return Ready™ offers organizations a customizable COVID-19 testing solution, clinical protocols and reporting to meet their unique worksite or campus needs

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that all initial European trial sites are active and enrolling or able to enroll patients into i